Microfluidics News Microfluidics News

  • Fluorescent biosensors as tools for drug therapeutics
    by Gina Mikalauskaite on 13th February 2019 at 9:16 am

      Researchers in the School of Pharmacy at the University of Nottingham have been using Dolomite Microfluidic’s chips to enhance their work on drug encapsulation and therapeutic delivery. Dr Veeren Chauhan, Research Fellow in the Advanced Materials and Healthcare Technologies (AMHT) group, working with Dr Jonathan Aylott and Dr Amjad Selo, explained: “We have been... The post Fluorescent biosensors as tools for drug therapeutics appeared first on Dolomite Microfluidics. […]

  • Making liposomal formulations for the delivery of RNA vaccines
    by Gina Mikalauskaite on 24th January 2019 at 9:55 am

      A Dolomite Microfluidics’ set-up for high throughput cell encapsulation is helping researchers at the Department of Medicine at Imperial College, London, to develop novel liposomal formulations for RNA vaccines targeting diseases such as HIV, influenza, rabies and chlamydia. Anna Blakney, Post-Doctoral Research Fellow, explained: “Our focus is on vaccine delivery, in particular liposomal formulations... The post Making liposomal formulations for the delivery of RNA vaccines appeared first on Dolomite Microfluidics. […]

  • Cambridge researchers developing self-healing concrete
    by Gina Mikalauskaite on 30th November 2018 at 10:29 am

      Researchers from the University of Cambridge are using microencapsulation technologies developed by Dolomite Microfluidics to create self-healing construction materials. The Geotechnical and Environmental Research Group are developing microcapsules containing ‘healing’ agents – such as exoxy or polyurethane – which can be added to building materials to allow self-repair of small cracks which develop over... The post Cambridge researchers developing self-healing concrete appeared first on Dolomite Microfluidics. […]

  • Dolomite Microfluidics highlights of MicroTAS 2018
    by Gina Mikalauskaite on 29th November 2018 at 12:27 pm

      Dolomite Microfluidics attended our biggest event of the year in November – MicroTAS! Here’s the lowdown on our time spent in Kaohsiung, Taiwan…   Our booth was set up and ready for action when the doors opened on Sunday 11th and more than 900 worldwide scientists and professionals flooded in! This year’s venue was an... The post Dolomite Microfluidics highlights of MicroTAS 2018 appeared first on Dolomite Microfluidics. […]

  • Labcyte Introduces the Echo 650 and 655 Liquid Handlers
    by Labcyte Inc. on 16th October 2018 at 12:00 am

    Labcyte Inc. today launched the Echo® 650 and 655 Liquid Handlers, which employ the unique capabilities of acoustic droplet ejection (ADE) technology with 2.5 nanoliter transfers. The 650 and 655 microplate-based systems include features to improve usability that were first made available in the recently launched 650T and 655T tube and microplate-enabled products. The 650 and 655 systems, which will be offered in addition to the Echo 500-series Liquid Handlers, are upgradeable to support transfers from Echo qualified acoustic sample tubes. Launched at the Society of Laboratory and Screening (SLAS) meeting in February and winner of the SLAS 2018 New Product Award, the Echo 650T and 655T Liquid Handlers incorporated several new features in addition to the ability to transfer liquids from Echo Qualified acoustic tubes. “We recognize that many of our users who work with our 550 or 555 systems are not ready to incorporate acoustic tubes into their workflows but may value the other advancements offered in our 650T and 655T systems,” said Chris Grimley, Vice President of Marketing at Labcyte. “We decided to make those features available to them in these new models, and at the same time provide them the ability to add the tube transfer capability when they are ready for it.” The new Echo 650 and 655 Liquid Handlers are based on the company’s patented acoustic droplet ejection technology, which uses the gentle energy of sound waves to move liquids at nanoliter resolution with superior precision and accuracy. The technology does not contact the liquid in any way, avoiding the risk for sample loss, carryover or cross-contamination. It also enables assay miniaturization with reliable fluid transfers at volumes as low as 2.5 nanoliters – saving time and cost, all while improving data quality. Echo Liquid Handlers are relied on throughout life science research to revolutionize workflows in drug discovery, genomics, synthetic biology, and precision medicine. The 600-series Echo systems feature an improved fluidics system with a simplified maintenance procedure. In addition, the new fluidics system no longer requires vacuum assist, resulting in quieter operation. Other improvements include an automated plate height adjustment, eliminating the need for physical microplate inserts, and simplifying robotic integration. These new features improve the overall usability of this next offering of Echo systems and result in less maintenance requirements. “Echo Acoustic Liquid Handlers have re-shaped life sciences by providing highly accurate, fully automated, touchless, low-volume dispensing of fluids,” said Mark Fischer-Colbrie, President and Chief Executive Officer at Labcyte. “With their high transfer accuracy and precision down to nanoliter volumes and with rapid any-well to any-well transfer capabilities, Echo Liquid Handlers have long been integral to state-of-art sample management and high-throughput screening solutions and hundreds of other applications. We are excited to introduce these product line extensions that offer the latest advancements to the broader community.” The company will be featuring the new systems at the upcoming SLAS Americas Sample Management Symposium in Boston. About Labcyte Inc. Labcyte, a global biotechnology tools company headquartered in San Jose, California, is revolutionizing liquid handling. Echo® Liquid Handlers use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical and biotechnology industries, as well as by hospitals, service laboratories, contract research organizations, and academic institutions. Our customers work across a wide spectrum of scientific research, including drug discovery, genomics, proteomics, diagnostics and personalized medicine. Labcyte has 63 U.S. patents and others internationally. For more information, visit www.labcyte.com. PR Contact for Labcyte Inc: Nicole Litchfield Bioscribe, Inc. (415) 793-6468 nicole@bioscribe.com […]

University of Toronto partners National Research Council to create a national research hub for microfluidics.

Shrinking entire medical labs onto chips with the help of nanotechnology